Evidence map›Paper›PMID 27571275›Full record

ArticleBiochemistry2016

Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.

Nathan Will, Andrea Piserchio, Isaac Snyder, Scarlet B Ferguson, David H Giles, Kevin N Dalby, Ranajeet Ghose

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Fine Mapping ofPlants (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nathan WillDepartment of Chemistry and Biochemistry, The City College of New York , New York, New York 10031, United States.
Andrea PiserchioDepartment of Chemistry and Biochemistry, The City College of New York , New York, New York 10031, United States.
Isaac SnyderDepartment of Chemistry and Biochemistry, The City College of New York , New York, New York 10031, United States.
Scarlet B FergusonDivision of Chemical Biology and Medicinal Chemistry, University of Texas , Austin, Texas 78712, United States.
David H GilesDivision of Chemical Biology and Medicinal Chemistry, University of Texas , Austin, Texas 78712, United States.
Kevin N DalbyDivision of Chemical Biology and Medicinal Chemistry, University of Texas , Austin, Texas 78712, United States.
Ranajeet GhoseDepartment of Chemistry and Biochemistry, The City College of New York , New York, New York 10031, United States.
City College of New York · USThe University of Texas at Austin · US

Funding

Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Mechanism and Specificity of MAP KinasesR01GM059802 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI DALBY, KEVIN N · 2001 to 2011
$2.3M
Catalytic Domain Dynamics in Protein KinasesR01GM084278 · NIGMS · CITY COLLEGE OF NEW YORK · PI GHOSE, RANAJEET · 2009 to 2013
$1.6M
NIGMS NIH HHS R01 GM059802NIGMS NIH HHS R01 GM084278NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

Eukaryotic elongation factor 2 kinase (eEF-2K) phosphorylates its only known physiological substrate, elongation factor 2 (eEF-2), which reduces the affinity of eEF-2 for the ribosome and results in an overall reduction in protein translation rates. The C-terminal region of eEF-2K, which is predicted to contain several SEL-1-like helical repeats (SLRs), is required for the phosphorylation of eEF-2. Using solution nuclear magnetic resonance methodology, we have determined the structure of a 99-residue fragment from the extreme C-terminus of eEF-2K (eEF-2K627-725) that encompasses a region previously suggested to be essential for eEF-2 phosphorylation. eEF-2K627-725 contains four helices, of which the first (αI) is flexible, and does not pack stably against the ordered helical core formed by the last three helices (αII-αIV). The helical core is structurally similar to members of the tetratricopeptide repeat (TPR) family that includes SLRs. The two penultimate helices, αII and αIII, comprise the TPR, and the last helix, αIV, appears to have a capping function. The eEF-2K627-725 structure illustrates that the C-terminal deletion that was shown to abolish eEF-2 phosphorylation does so by destabilizing αIV and, therefore, the helical core. Indeed, mutation of two conserved C-terminal tyrosines (Y712A/Y713A) in eEF-2K previously shown to abolish eEF-2 phosphorylation leads to the unfolding of eEF-2K627-725. Preliminary functional analyses indicate that neither a peptide encoding a region deemed crucial for eEF-2 binding nor isolated eEF-2K627-725 inhibits eEF-2 phosphorylation by full-length eEF-2K. Taken together, our data suggest that the extreme C-terminal region of eEF-2K, in isolation, does not provide a primary docking site for eEF-2.

Indexed as

AnimalsElongation Factor 2 KinaseNuclear Magnetic Resonance, BiomolecularPhosphorylationProtein ConformationElongation Factor 2 Kinase

Identifiers

PMID27571275
PMCPMC5266509
OpenAlexW2517627835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.